🇺🇸 Anti-TNF in United States

20 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arrhythmia — 2 reports (10%)
  2. Arthralgia — 2 reports (10%)
  3. Colitis Ulcerative — 2 reports (10%)
  4. Depression — 2 reports (10%)
  5. Diarrhoea — 2 reports (10%)
  6. Hypertension — 2 reports (10%)
  7. Nausea — 2 reports (10%)
  8. Pulmonary Fibrosis — 2 reports (10%)
  9. Urticaria — 2 reports (10%)
  10. Vomiting — 2 reports (10%)

Source database →

Anti-TNF in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Anti-TNF approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Anti-TNF in United States?

Abu Dhabi Stem Cells Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.